What Researchers Did
The researchers surveyed medical directors of hyperbaric oxygen (HBO) facilities in the United States and Canada to find out which patients they treat for acute carbon monoxide (CO) poisoning.
What They Found
This survey of North American hyperbaric facilities found that most treat CO-poisoned patients with coma, loss of consciousness, heart ECG changes or nerve problems regardless of carboxyhemoglobin (COHb) level, though criteria for other patients varied widely. Responses came from 85% of 208 facilities. Among responders, 89 monoplace and 58 multiplace facilities treat acute CO poisoning and managed 2,636 patients in 1992. Most facilities treat patients with coma (98%), transient loss of consciousness (77%), ischemic ECG changes (91%), focal neurologic deficits (94%), or abnormal psychometric testing (91%), regardless of COHb level. Only 62% use a specified minimum COHb level as the sole criterion for an asymptomatic patient, and the level used varies widely. Half of facilities limit the delay to treatment for patients with only transient loss of consciousness.
What This Means for Canadian Patients
The abstract describes what facilities report doing, not how well treatment works. Patients with CO poisoning who have coma, loss of consciousness, heart changes or neurologic problems were commonly treated with HBO by these facilities. Whether a patient is treated may also depend on the facility, since the abstract says criteria varied.
Canadian Relevance
The survey covered facilities in both the United States and Canada, but the abstract does not give a separate Canadian breakdown.
Study Limitations
The study is a survey of opinions and practice, so it does not measure patient outcomes or show that any selection criterion leads to better results, and the abstract notes that variability exists between facilities.